I took a screenshot of that NYTimes article which discussed how difficult even BP was having enrolling their trials. It was just a few weeks ago and was a much discussed article. I referred back to it just now. Regeneron stated their “initial results were pushed back to end of September” and Eli Lilly said theirs would be “end of this year.”
I believe plasma is still on hold and that’s mesoblast, MBLT, correct? So that shouldn’t be it. RLFTF is still going through trials so it’s not ready. We’re the only one that it could be unless one of these others the president has just decided to give leapfrog status to in order to excite everyone before the convention because he had nothing else and hasn’t been told about Cydy. Since Hahn will be there it should only be a drug which has completed a trial successfully. There’s the OWS and “ get better in 3 days with a shot” which sounds like us. Perhaps the delay has been trying to figure out how to get this drug to the masses before it’s announced. And Rem shouldn’t be it because the JAMA just said it sucks and it’s not “breakthrough”. Have I covered all the bases?